Moogene Medi Co., Ltd. (XKON:322970)
South Korea · Delayed Price · Currency is KRW 2,385.00
+10.00 (0.42%)
At close: May 29, 2026
Moogene Medi Market Cap
Moogene Medi has a market cap or net worth of 23.97 billion as of May 29, 2026. Its market cap has increased by 11.45% in one year.
Market Cap
23.97B
Enterprise Value
n/a
Revenue
12.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,385.00
Market Cap Chart
Since June 24, 2020, Moogene Medi's market cap has decreased from 39.69B to 23.97B, a decrease of -39.60%. That is a compound annual growth rate of -8.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 23.97B | 19.67% |
| Dec 30, 2025 | 20.03B | -14.46% |
| Dec 30, 2024 | 23.42B | 26.91% |
| Dec 28, 2023 | 18.45B | -30.26% |
| Dec 29, 2022 | 26.46B | -11.50% |
| Dec 30, 2021 | 29.90B | -25.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADBiotech | 52.25B |
| HLB Pep | 51.67B |
| Parataxis Korea | 44.13B |
| Aptamer Sciences | 40.06B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |
| Epibiotech | 32.27B |
| NGeneBio | 28.69B |